Stock Track | LivaNova PLC Plummets 5.27% as Q4 Earnings Disappoint and 2025 Guidance Lags Estimates

Stock Track

Feb 25

LivaNova PLC (LIVN) stock plummeted 5.27% in Tuesday's pre-market trading session, underperforming the broader market. The medical technology company reported mixed fourth-quarter results, with earnings beating estimates but revenue missing expectations.

For Q4, LivaNova reported adjusted earnings per share of $0.81, slightly above the consensus estimate of $0.80. However, revenue came in at $321.8 million, missing analysts' expectations of $324.1 million. The company's full-year revenue grew by 3.77% compared to the previous year.

Furthermore, LivaNova's 2025 guidance disappointed investors. The company expects adjusted EPS in the range of $3.65 to $3.75, slightly below the FactSet consensus estimate of $3.66. Revenue growth is projected to be between 5% and 6% on a constant-currency basis and 6% to 7% on an organic basis.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1133189186"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133189186\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133189186?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133189186","market":"us","top_or_hot":-1,"title":"Stock Track | LivaNova PLC Plummets 5.27% as Q4 Earnings Disappoint and 2025 Guidance Lags Estimates","media":"Stock Track","content":"<p>LivaNova PLC (LIVN) stock plummeted 5.27% in Tuesday's pre-market trading session, underperforming the broader market. The medical technology company reported mixed fourth-quarter results, with earnings beating estimates but revenue missing expectations.</p>\n\n<p>For Q4, LivaNova reported adjusted earnings per share of $0.81, slightly above the consensus estimate of $0.80. However, revenue came in at $321.8 million, missing analysts' expectations of $324.1 million. The company's full-year revenue grew by 3.77% compared to the previous year.</p>\n\n<p>Furthermore, LivaNova's 2025 guidance disappointed investors. The company expects adjusted EPS in the range of $3.65 to $3.75, slightly below the FactSet consensus estimate of $3.66. Revenue growth is projected to be between 5% and 6% on a constant-currency basis and 6% to 7% on an organic basis.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LivaNova PLC Plummets 5.27% as Q4 Earnings Disappoint and 2025 Guidance Lags Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LivaNova PLC Plummets 5.27% as Q4 Earnings Disappoint and 2025 Guidance Lags Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-25 22:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LivaNova PLC (LIVN) stock plummeted 5.27% in Tuesday's pre-market trading session, underperforming the broader market. The medical technology company reported mixed fourth-quarter results, with earnings beating estimates but revenue missing expectations.</p>\n\n<p>For Q4, LivaNova reported adjusted earnings per share of $0.81, slightly above the consensus estimate of $0.80. However, revenue came in at $321.8 million, missing analysts' expectations of $324.1 million. The company's full-year revenue grew by 3.77% compared to the previous year.</p>\n\n<p>Furthermore, LivaNova's 2025 guidance disappointed investors. The company expects adjusted EPS in the range of $3.65 to $3.75, slightly below the FactSet consensus estimate of $3.66. Revenue growth is projected to be between 5% and 6% on a constant-currency basis and 6% to 7% on an organic basis.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIVN","symbol_name":"LivaNova PLC","start_time":0,"source_url":"","article_id":"1133189186","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133189186","pubTimestamp":1740494061,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"LivaNova PLC  stock plummeted 5.27% in Tuesday's pre-market trading session, underperforming the broader market. The medical technology company reported mixed fourth-quarter results, with earnings beating estimates but revenue missing expectations.For Q4, LivaNova reported adjusted earnings per share of $0.81, slightly above the consensus estimate of $0.80. However, revenue came in at $321.8 million, missing analysts' expectations of $324.1 million. The company's full-year revenue grew by 3.77% ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LIVN":"LivaNova PLC"},"translate_title":"由于第四季度盈利令人失望且2025年指引落后于预期，LivaNova PLC股价暴跌5.27%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIVN":1},"content_text":"LivaNova PLC (LIVN) stock plummeted 5.27% in Tuesday's pre-market trading session, underperforming the broader market. The medical technology company reported mixed fourth-quarter results, with earnings beating estimates but revenue missing expectations.\nFor Q4, LivaNova reported adjusted earnings per share of $0.81, slightly above the consensus estimate of $0.80. However, revenue came in at $321.8 million, missing analysts' expectations of $324.1 million. The company's full-year revenue grew by 3.77% compared to the previous year.\nFurthermore, LivaNova's 2025 guidance disappointed investors. The company expects adjusted EPS in the range of $3.65 to $3.75, slightly below the FactSet consensus estimate of $3.66. Revenue growth is projected to be between 5% and 6% on a constant-currency basis and 6% to 7% on an organic basis.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}